Evidence map›Paper›PMID 20920664›Full record

ArticleAmerican journal of human genetics2010

Understanding FDA regulation of DTC genetic tests within the context of administrative law.

Jennifer K Wagner

Abstract read
In one paragraph

Article in American journal of human genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. The Federal Trade Commission and Consumer Protections for Mobile Health Apps.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2020
    Article
  3. Article
  4. Direct-to-consumer genetic testing: a comprehensive view.The Yale journal of biology and medicine · 2013
    Article
  5. Recent developments in health care law: culture and controversy.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2013
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jennifer K WagnerInstitute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA. jkw23@duke.edu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

How the FDA should regulate direct-to-consumer genetic tests is fiercely contested. Passing a rule or issuing an order is only one down in the series. There is more to the regulatory game.

Indexed as

Government RegulationConsumer Product SafetyGenetic TestingUnited StatesUnited States Food and Drug Administration

Identifiers

PMID20920664
PMCPMC2948799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.